Abstract Number: 1791 • 2018 ACR/ARHP Annual Meeting
Efficacy of Apremilast for Oral Ulcers Associated with Active Behçet’s Syndrome in a Phase III Study: A Prespecified Analysis By Baseline Patient Demographics and Disease Characteristics
Background/Purpose: Behçet’s syndrome is a chronic, multi-system inflammatory disorder characterized by recurrent oral ulcers (OU) that can be disabling and negatively affect quality of life.…Abstract Number: 1792 • 2018 ACR/ARHP Annual Meeting
Work Productivity Is Impaired in Patients with Behcet’s Syndrome
Background/Purpose: Behcet’s syndrome (BS) is most active during young adulthood and working years, thus affecting productivity. Work disability was previously reported especially among BS patients…Abstract Number: 1793 • 2018 ACR/ARHP Annual Meeting
The Omeract Core Domain Set for Clinical Trials in Behçet’s Syndrome
Background/Purpose: There is an unmet need for reliable, validated, and widely-accepted outcome measures for clinical trials in Behçet’s syndrome (BS). The Outcome Measures in Rheumatology…Abstract Number: 1794 • 2018 ACR/ARHP Annual Meeting
Venous Vessel Wall Thickness in Lower Extremity Is Increased in Male Behcet’s Disease Patients
Background/Purpose: Vascular involvement is seen in up to 40% of the patients with Behcet's Disease (BD), especially in young males and is one of the…Abstract Number: 1795 • 2018 ACR/ARHP Annual Meeting
New Major Organ Involvement Is Lower in Young Male Behçet’s Patients Compared to Retrospective Series: Five-Year Results of a Prospective Cohort
Background/Purpose: Major organ involvement such as vascular or ocular disease, especially in young males, is one of the main causes of mortality and morbidity in…Abstract Number: 1796 • 2018 ACR/ARHP Annual Meeting
Retrospective Analysis of Initial Presentation Findings of Behcet’s Syndrome throughout 4 Decades
Background/Purpose: There is some evidence that incident Behcet’s syndrome (BS) might be becoming less severe (1, 2). We compared clinical findings at presentation of BS…Abstract Number: 1797 • 2018 ACR/ARHP Annual Meeting
An Update on Pulmonary Artery Involvement in Behcet’s Syndrome: More Pulmonary Artery Thrombotic Disease and a Better Outcome
Background/Purpose: Pulmonary artery involvement (PAI) is the most common form of arterial involvement in Behçet’s syndrome (BS). A previous survey (1) by our group had…Abstract Number: 1798 • 2018 ACR/ARHP Annual Meeting
Leg Ulcers in Behçet’s Syndrome: An Observational Survey in 24 Patients
Background/Purpose: Formal experience with leg ulcers in Behcet’s syndrome (BS) is limited. It is a relatively rare complication that can be seen during the course…Abstract Number: 1799 • 2018 ACR/ARHP Annual Meeting
Increased Vein Wall Thickness in Behçet’s Syndrome
Background/Purpose: Lower extremity vein thrombosis (LEVT) is the key feature of vascular involvement in Behçet’s syndrome (BS).Vein wall thickness (VWT) is proposed to be a…Abstract Number: 1800 • 2018 ACR/ARHP Annual Meeting
A Declining Trend in Frequency of Secondary Amyloidosis in Behçet’s Syndrome
Background/Purpose: A decline in the frequency of AA amyloidosis secondary to RA and infectious diseases has been reported. This is probably due to more effective…Abstract Number: 1801 • 2018 ACR/ARHP Annual Meeting
Factors Associated with Damage Progression in Behçet’s Syndrome Uveitis
Background/Purpose: Uveitis in Behçet’s syndrome (BS) follows a recurrent disease course with inflammatory exacerbations causing damage in the uvea, retina and optic nerve even with…Abstract Number: 1802 • 2018 ACR/ARHP Annual Meeting
Behcet’s Disease in the Southwestern United States
Background/Purpose: Behcet’s disease (BD) in the US is estimated to have a prevalence of 5.2-6.6 per 100,000 populations which is similar to that of European…Abstract Number: 1803 • 2018 ACR/ARHP Annual Meeting
Assessment of Severity and Risk Factors of Post-Thrombotic Syndrome in Vascular Behçet Disease: Muticentered Retrospective Study
Background/Purpose: Vascular involvement is seen in about one third of patients with Behçet Disease(BD). DVT(deep venous thrombosis) is the most common form of vascular Behçet…Abstract Number: 1804 • 2018 ACR/ARHP Annual Meeting
Optimization Protocol for Adalimumab Treatment in Refractory Uveitis Due to Behçet’s Disease
Background/Purpose: Uveitis is the most common ocular manifestation in Behçet Disease (BD), which can cause irreversible blindness. Once the efficacy, safety and cost-effectiveness of Adalimumab…Abstract Number: 1805 • 2018 ACR/ARHP Annual Meeting
Strong Association of HLA-DRB1*0901 with Japanese Patients with Chronic Progressive Neuro-Behçet’s Disease
Background/Purpose: Central nervous system involvement is one of the most serious complications in Behçetfs disease (BD). This condition is referred to as neuro-BD (NB) and…
ACR Meeting Abstracts